Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae.
about
Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretionsMucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of miceThe L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes.Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers.Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18The role of vaccines in the control of STDs: HPV vaccines.Papillomavirus-like particle based vaccines: cervical cancer and beyond.Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay.Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.Self-assembly of in vitro-translated human papillomavirus type 16 L1 capsid protein into virus-like particles and antigenic reactivity of the protein.Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice.Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein.Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.Vaccines against cervical cancer.The evolving field of human papillomavirus receptor research: a review of binding and entry.Virus-like particles: flexible platforms for vaccine development.Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineagesExpression and characterization of HPV-16 L1 capsid protein in Pichia pastoris.Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol use.Construction and characterization of virus-like particles: a review.Yeast as an expression system for producing virus-like particles: what factors do we need to consider?Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro.Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11.A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope.Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2Parenteral and oral immunization with a plasmid DNA expressing the human papillomavirus 16-L1 gene induces systemic and mucosal antibodies and cytotoxic T lymphocyte responses.Development a scalable production process for truncated human papillomavirus type-6 L1 protein using WAVE Bioreactor and hollow fiber membrane.Yeast cells allow high-level expression and formation of polyomavirus-like particles.
P2860
Q33784891-FC03B974-052E-4222-8EB8-32B51B5F7F63Q33823755-2247572A-DBCC-438F-B22D-6A4FEDAC9D83Q33852592-4FA093E3-2C9D-4EC4-BBBB-84BDAFC2C566Q33853398-59962AA0-C471-458B-BE14-CE42DDB092EEQ33908917-90494F83-9F39-476F-B6B4-DDDC2C6039B4Q33910699-6774BA9E-D229-4287-B2F9-DFB907B22C9DQ33936363-6A1546F0-D8E1-47CE-BF59-F48A93AC0EEDQ34451862-735FC646-B0BF-44EE-9C69-B987746A8F96Q34579346-6DE04039-8C8E-435C-88E8-2F6367CB1359Q34995733-9F9F34E7-13D0-426A-A591-E7DB03C81CE5Q35228223-AAC70FDD-E695-482F-B9A1-470FA4D35956Q35228978-F6674819-4866-46EA-A0C0-B5968633EE60Q35553171-D9CE9428-6EE9-40C2-9EEB-0FFD0B99B5D9Q35595612-CFB40118-3691-4377-9B90-FE9020DC3351Q35775195-B560E3DC-4677-4EB8-AC22-5D1A789D7BF6Q35925621-1AF3C518-DCB9-41FD-845E-6087AEA4F9D5Q36827213-6B73E9BE-00CE-441E-BE44-07E1361CB6FAQ36837144-CE47448D-393C-430A-84CD-B31E0929DC93Q36948919-3F9C53ED-3644-4D26-B3F9-67344621B022Q37280045-85ADA2B1-B11A-4B7E-8C73-E4FD85CC1CEDQ37321783-5291EA01-F41E-4DAE-99B1-0E47233851A1Q38045834-A7725F09-B32A-4E89-99A2-F58982FEDA17Q39012245-EB4DE7CB-C51D-4DB8-8D1F-FA692AD16BF7Q39577044-3D4A5B0C-BD48-444E-90B0-ADB7CF691AD1Q39875296-E4823B7A-3094-4B18-BD8D-E4E28B357E21Q39879423-3235DA33-0CE7-45E1-A918-8B8F5A9C2F63Q39880986-E37DAAD9-6F1F-49AA-8A7C-9A83660D3F2CQ40762506-A010139E-665E-4E58-B825-F271E97F0333Q40962204-8FC8DC69-6D9E-4F21-8ED1-DFE2AB9C7A27Q45857869-C54A20F5-1DD9-4A65-97FE-5C242780712B
P2860
Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Sequence determination of huma ...... s in Saccharomyces cerevisiae.
@en
Sequence determination of huma ...... s in Saccharomyces cerevisiae.
@nl
type
label
Sequence determination of huma ...... s in Saccharomyces cerevisiae.
@en
Sequence determination of huma ...... s in Saccharomyces cerevisiae.
@nl
prefLabel
Sequence determination of huma ...... s in Saccharomyces cerevisiae.
@en
Sequence determination of huma ...... s in Saccharomyces cerevisiae.
@nl
P2093
P356
P1433
P1476
Sequence determination of huma ...... s in Saccharomyces cerevisiae.
@en
P2093
Hofmann KJ
Rosolowsky M
Schultz LD
P304
P356
10.1006/VIRO.1995.1283
P407
P577
1995-06-01T00:00:00Z